Loading...
What explains the differences between centres in the European screening trial? A simulation study
BACKGROUND: The European Randomised study of Screening for Prostate Cancer (ERSPC) is a multicentre, randomised screening trial on men aged 55-69 years at baseline without known prostate cancer (PrCa) at randomisation to an intervention arm invited to screening or to a control arm. The ERSPC has sho...
Na minha lista:
| Udgivet i: | Cancer Epidemiol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5415347/ https://ncbi.nlm.nih.gov/pubmed/27889661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canep.2016.11.005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|